SCHEMBL103841

SCHEMBL103841

COc1cccc(C#N)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 1/20 0.55
ACHE P22303 1/20 0.50
AR P10275 1/20 0.50
MCHR1 Q99705 1/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA9 Q16790 3/20 0.49
GRM5 P41594 2/20 0.49
CA12 O43570 2/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
CA7 P43166 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
SNCA P37840 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HPGDS O60760 1/20 0.46
PDE4A P27815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30083320 1.00 P4HB (0.55) P4HBACHEARMCHR1CA1
SCHEMBL921247 0.92 SMN1; SMN2 (0.53) P4HBACHEARMCHR1CA1
Ammonia Solution, Strong SCHEMBL3948300 0.91 P4HB (0.49) P4HBACHEARMCHR1CA1
O-Xylene SCHEMBL29065565 0.91 AR (0.50) P4HBACHEARMCHR1CA1
SCHEMBL7446928 0.88 PGR (0.55) P4HBARALDH1A1CYP3A4SLC6A2
SCHEMBL28311183 0.88 P4HB (0.50) P4HBARMCHR1CA1CA2
SCHEMBL18641303 0.87 LTA4H (0.53) P4HBARMCHR1ALDH1A1CYP3A4
SCHEMBL18641302 0.84 RAB9A (0.50) P4HBMCHR1ALDH1A1RAB9A
SCHEMBL18641322 0.84 P4HB (0.47) P4HBACHEARMCHR1SNCA
SCHEMBL25014569 0.82 CYP1A1 (0.65) P4HBARALDH1A1CYP3A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260002924-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2026-01-01 US claimed
WO-2025057535-A1 SEPARATION MEMBRANE 日東電工株式会社 2025-03-20 WO claimed
EP-4477693-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS Korea Research Institute of Chemical Technology (KR) 2024-12-18 EP claimed
EP-4255947-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2024-07-03 EP claimed
CN-116874392-B Preparation method of non-steroidal selective salt corticoid receptor antagonist intermediate 4-aldehyde-3-methoxybenzonitrile 山东轩硕医药科技有限公司 2024-05-14 CN claimed
CN-114828959-B 3- (5-methoxy-1-oxo-isoindolin-2-yl) piperidine-2, 6-dione derivative and application thereof 诺华股份有限公司 2024-04-02 CN claimed
US-20240026065-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2024-01-25 US claimed
CN-116874392-A Preparation method of non-steroidal selective salt corticoid receptor antagonist intermediate 4-aldehyde-3-methoxybenzonitrile 山东轩硕医药科技有限公司 2023-10-13 CN claimed
CN-116529281-A Process for producing thermoplastic polyoxazolidone polymers 科思创德国股份有限公司 2023-08-01 CN claimed
CN-113024530-B Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof 合肥工业大学 2023-07-18 CN claimed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP claimed
EP-0639587-B1 Diene polymers and copolymers terminated with compounds having multiple-bonded nitrogen atoms and partially crosslinked with polyfunctional reagents BRIDGESTONE FIRESTONE INC (US) 1997-10-22 EP claimed
EP-0543128-B1 Diene polymers and copolymers terminated by reaction with aromatic nitriles BRIDGESTONE FIRESTONE INC (US) 1997-01-08 EP claimed
EP-0543305-B1 Diene polymers having reduced hysteresis and improved raw viscosity incorporating primary partial coupling and terminals formed from fused-ring polynuclear aromatic compounds or aromatic nitrile compounds BRIDGESTONE CORP (JP) 1995-10-11 EP claimed
EP-0639587-A1 Diene polymeres and copolymers terminated with compounds having multiple-bonded nitrogen atoms and partially crosslinked with polyfunctional reagents BRIDGESTONE/FIRESTONE, INC. (US) 1995-02-22 EP claimed
US-5310798-A Tire treads BRIDGESTONE/FIRESTONE, INC. (US) 1994-05-10 US claimed
US-5254628-A Diene polymers having reduced hysteresis and improved raw viscosity incorporating primary partial coupling and terminals formed from aromatic nitrile compounds BRIDGESTONE CORPORATION (JP) 1993-10-19 US claimed
EP-0543128-A1 Diene polymers and copolymers terminated by reaction with aromatic nitriles BRIDGESTONE/FIRESTONE, INC. (US) 1993-05-26 EP claimed
EP-0543305-A1 Diene polymers having reduced hysteresis and improved raw viscosity incorporating primary partial coupling and terminals formed from fused-ring polynuclear aromatic compounds or aromatic nitrile compounds BRIDGESTONE CORPORATION (JP) 1993-05-26 EP claimed
US-5153271-A Conjugated homo- or copolyenes, aromatic olefin copolymers endcapped by benzonitrile(or derivataives), for reduced hystersis in tire treads BRIDGESTONE/FIRESTONE, INC. (US) 1992-10-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002924-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS FGB, NR4A1, CYP2E1 P4HB 203/4885ACHE 1251/4885AR 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.